Intervention

Rasagiline

ClinicalTrials.gov intervention label

Explore related research

Search across original and mapped records

Search results distinguish clinical terminology from original registry names. Shared trial participation does not imply treatment or approval.

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 23 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials23
Recruiting0
Common conditions12
Lead sponsors shown15
Advertisement

Clinical trials

23 shown
Efficacy and Safety of Rasagiline in Prodromal Parkinson's DiseaseNCT05611372 · 2023-01-01
WITHDRAWN
Rasagiline Tablets Special Drug Use-Results Survey "Survey on Long-term Safety"NCT03727139 · 2018-11-01
COMPLETED
Image Parkinson's Disease Progression StudyNCT02789020 · 2016-12-01
COMPLETED
Rasagiline Rescue in Alzheimer's Disease Clinical TrialNCT02359552 · 2015-05-01
COMPLETED
Effect of 2.5 Years of Rasagiline Therapy on Progression of Cognitive Biomarkers Assessed by MRI in Parkinson's Disease.NCT02278588 · 2014-11-01
COMPLETED
A Study to Assess the Pharmacokinetics, Safety, and Tolerability of Single and Multiple Doses of RasagilineNCT01879748 · 2013-06-01
COMPLETED
Parallel-Group Study to Assess the Effect of Rasagiline on Cognition in Patients With Parkinson's DiseaseNCT01723228 · 2012-11-01
COMPLETED
Pharmacokinetic Properties of Rasagiline (Lu 00-773) in Healthy Young Chinese Men and WomenNCT01652313 · 2012-05-01
COMPLETED
A Double Blind Placebo Controlled Trial Evaluating Rasagiline Effects on Cognition in Parkinson's Disease Patients With Mild Cognitive Impairment Receiving Dopaminergic TherapyNCT01497652 · 2012-01-01
COMPLETED
Clinical Trial of Rasagiline in Levodopa-Treated Parkinson's Disease Patients With Motor FluctuationsNCT01736891 · 2011-11-01
COMPLETED
Emotion, Mood and Executive Function in Parkinson's Disease (PD)NCT01385735 · 2011-10-01
UNKNOWN
Effects of Rasagiline on Sleep Disturbances in Parkinson's DiseaseNCT01442610 · 2011-10-01
COMPLETED
Multicenter Placebo Controlled Study to Assess the Effect of Rasagiline on Sleep-wake Disturbances in Patients With Parkinson's DiseaseNCT01178047 · 2011-09-01
TERMINATED
The Effect of Rasagiline on Cognition in Parkinson's DiseaseNCT01382342 · 2011-06-01
COMPLETED
An Active-Controlled Extension Study to NCT01155466 [P04938] and NCT01227265 [P07037] (P06153)NCT01215227 · 2010-11-18
TERMINATED
Rasagiline in Cognitive-impairment Related Depression: AzileCt in COgnitive-impairment Related DepressiOnNCT01055379 · 2010-03-01
COMPLETED
Rasagiline for the Symptomatic Treatment of Fatigue in Parkinson's DiseaseNCT01168596 · 2009-12-01
COMPLETED
Rasagiline as Add on to Dopamine Agonists in the Treatment of Parkinson's DiseaseNCT01049984 · 2009-12-01
COMPLETED
Effect of Rasagiline on BIA 9-1067 PharmacokineticsNCT01532141 · 2009-11-01
COMPLETED
A Study Assessing Change in Sense of Smell After Rasagiline Use in Parkinson's PatientsNCT01007630 · 2009-11-01
UNKNOWN
Evaluation of the Tolerance and Acceptability of Rasagiline in the Treatment of Early-stage Parkinson's DiseaseNCT01048229 · 2008-10-01
TERMINATED
Rasagiline and Apathy in Parkinson's DiseaseNCT00755027 · 2008-09-01
COMPLETED
Rasagiline 1 mg and 2 mg Added to Aricept 10 mg Daily in Patients With Mild to Moderate Alzheimer's Disease (AD)NCT00104273 · 2004-08-01
COMPLETED

Leading sponsors

Trial status mix

COMPLETED17
TERMINATED3
UNKNOWN2
WITHDRAWN1

Phase mix

PHASE412
PHASE24
PHASE13
PHASE33
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.